These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3942906)

  • 1. High-affinity hemicholinium-3 binding to brain membranes: reduction by treatment with physostigmine in vivo.
    Swann AC; Hewitt LO; Guynn RW
    Brain Res; 1986 Jan; 363(2):401-3. PubMed ID: 3942906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of [3H]hemicholinium-3 binding to rat striatal membranes: evidence for negative cooperative site-site interactions.
    Chatterjee TK; Cannon JG; Bhatnagar RK
    J Neurochem; 1987 Oct; 49(4):1191-201. PubMed ID: 3625204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of endogenous acetylcholine from rat brain slices with or without cholinesterase inhibition and its potentiation by hemicholinium-3.
    Umeda Y; Sumi T
    Neurosci Lett; 1990 Oct; 118(2):276-8. PubMed ID: 2274284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the biochemical characterization and autoradiographic distribution of [3H]hemicholinium-3 binding sites in rat brain: a presynaptic cholinergic marker.
    Pascual J; Gonzalez AM; Pazos A
    Pharmacol Res; 1991 Dec; 24(4):345-55. PubMed ID: 1805188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]hemicholinium-3 binding sites in human brain membranes: a marker for presynaptic cholinergic nerve terminals.
    Pascual J; González AM; Pazos A
    J Neurochem; 1990 Mar; 54(3):792-800. PubMed ID: 2303811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemicholinium-3 and physostigmine on choline in rat brain.
    Slone HT; Kosh JW; Freeman JJ
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):133-6. PubMed ID: 3715194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and characterization of a [3H]hemicholinium-3 binding site in rat brain.
    Yamada K; Saltarelli MD; Coyle JT
    J Neurochem; 1988 Jun; 50(6):1759-64. PubMed ID: 3373214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of slow cooling in situ and freeze-thaw procedures on [3H]hemicholinium-3 binding in rat cerebral cortical plasma membranes.
    Hautamaki RD; Meyer EM
    Biochem Pharmacol; 1987 Feb; 36(4):561-2. PubMed ID: 3827941
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease in [3H]hemicholinium binding to high-affinity choline uptake sites in deafferented striatum: restoration by oxiracetam.
    Forloni G; Angeretti N; Amoroso D; Addis A; Consolo S
    Brain Res; 1990 Oct; 530(1):156-60. PubMed ID: 2271947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-dependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites.
    Vickroy TW; Roeske WR; Yamamura HI
    Life Sci; 1984 Dec; 35(23):2335-43. PubMed ID: 6503616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemicholinium-3 binding: correlation with high-affinity choline uptake during changes in cholinergic activity.
    Swann AC; Hewitt LO
    Neuropharmacology; 1988 Jun; 27(6):611-5. PubMed ID: 3419544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of high-affinity choline transport sites in rat forebrain: a quantitative autoradiography study with [3H]hemicholinium-3.
    Happe HK; Murrin LC
    J Comp Neurol; 1992 Jul; 321(4):591-611. PubMed ID: 1506485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [3H]hemicholinium-3 binding associated with neuronal choline uptake sites in rat brain membranes.
    Sandberg K; Coyle JT
    Brain Res; 1985 Dec; 348(2):321-30. PubMed ID: 4075090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices.
    Saltarelli MD; Lowenstein PR; Coyle JT
    Eur J Pharmacol; 1987 Mar; 135(1):35-40. PubMed ID: 3569424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
    Yamada K; Saltarelli MD; Coyle JT
    J Pharmacol Exp Ther; 1989 Jun; 249(3):836-42. PubMed ID: 2732947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of physostigmine on acetylcholinesterase activity of CSF plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs.
    Mattio T; McIlhany M; Giacobini E; Hallak M
    Neuropharmacology; 1986 Oct; 25(10):1167-77. PubMed ID: 3785584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity choline transport regulation by drug administration during postnatal development.
    Happe HK; Murrin LC
    J Neurochem; 1992 Jun; 58(6):2053-9. PubMed ID: 1573392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased [3H]hemicholinium binding to high-affinity choline uptake sites in aged rat brain.
    Forloni G; Angeretti N
    Brain Res; 1992 Jan; 570(1-2):354-7. PubMed ID: 1617427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain.
    Alberch J; Carman-Krzan M; Fabrazzo M; Wise BC
    Brain Res; 1991 Mar; 542(2):233-40. PubMed ID: 1851454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo identification of muscarinic cholinergic receptor binding in rat brain.
    Yamamura HI; Kuhar MJ; Snyder SH
    Brain Res; 1974 Nov; 80(1):170-6. PubMed ID: 4421615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.